New paper out from our lab! Targeting the “diffuse” in diffuse midline glioma? Pediatric brain tumor cell invasion and migration can be slowed through inhibition of the protein ID1. Quick explainer🧵below by first author Dana M. ... 1/n academic.oup.com/neuro-oncology…

Congrats! It was great to collaborate on this project and glad to have you here. Look out for more work by Jack Wadden developing rapid, easy-to-perform, accurate, and low-cost liquid biopsy assays to track treatment response in our #DMG/#DIPG peds patients.

New review from our lab published in Frontiers - Oncology (led by MDPhD student Kallen Schwark and Vivekanand Yadav Children's Mercy Research Institute) describing the existing state of targeted tyrosine kinase inhibitor use in preclinical models and clinical trials of pediatric high-grade glioma. Check it out!

Amazing to host Meghan Behen and little Mac from the #MorganBehenGolfClassic. Meghan hand delivered a check to fund a new qPCR machine in lab (!!!) We are so grateful for your generosity and will continue to fight for DIPG patients and families #MorganStrong #EndDIPG

Thank you ChadTough Defeat DIPG Foundation and Tammi Carr for organizing this amazing event to defeat DIPG! Mark Mosier Jenny Mosier C.S. Mott Children's U-M Rogel Cancer Center #DIPG

It was such an honor to win a poster award at the @CBTNetwork summit! Thanks for a day of such interesting talks!

Was lucky enough to get to present my poster at the SNO conference last weekend! Koschmann Lab

Thank you Swenson family! So lucky to be involved in such important work

Star PhD student Dana M. wrote this blog post describing the very complex way H3K27M mutations cause DIPG/DMGs in a way that's **accessible to non-experts**. Beautifully written and a great resource for patients, families, and non-experts alike! misciwriters.com/2024/02/07/the…

So excited to work on this project! Active Motif